KUKJE PHARM CO.,LTD
bd_4f3ae781aa5509b1 · schema v1 · pii pii-v1
Full breach record for KUKJE PHARM CO.,LTD →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Gunra on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
KUKJE PHARM CO., LTD is a South Korean pharmaceutical company engaged in the manufacture and distribution of pharmaceutical products. The company operates within the healthcare and life sciences industry, producing medicines and related chemical compounds for both domestic and international markets. Based in South Korea, it is part of the country's established pharmaceutical manufacturing sector.
J jump to incidentP pin to compareR raw source
Incident timeline — mostly unverified
? — ?
Breach window unknown
Apr 8, 2026
Claim posted
—
No filing yet · watching
Compliance clocks stay unassessable until a regulatory filing lands. Dashed segments fill in automatically when corroboration arrives.
Claim → filing
—
Compliance clock
Not assessable
Evidence ladder
Attacker assertion only. Establishes: claim date, group, alleged victim.
Unlocks: incident narrative, operational impact. Still no compliance clock.
Unlocks: discovery date, data types, affected count, compliance clock.
Unlocks: materiality, stated response, full audit trail. Ceiling removed.
No regulatory filing corroborates this yet — it is the attacker's own assertion. Watch this entity to be notified the moment a filing corroborates or contradicts it.
Source ceiling
- actor name
- victim claim
- ransom/leak status
- discovery date
- materiality
- notification
- affected count
- confirmed data types
- compliance clock
The ✕ fields stay blank until a regulatory filing or victim disclosure lands.
gunra
According to ransomware.live, Gunra is a financially motivated ransomware group that emerged in April 2025, using double-extortion tactics against real estate, pharmaceuticals, and manufacturing sectors across Japan, Egypt, Panama, Italy, and Argentina, deploying separate Windows and Linux variants with a strict five-day payment deadline.